Home/Filings/4/0001894562-24-000047
4//SEC Filing

Reine Allan 4

Accession 0001894562-24-000047

CIK 0001894562other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 6:22 PM ET

Size

5.5 KB

Accession

0001894562-24-000047

Insider Transaction Report

Form 4
Period: 2024-12-05
Reine Allan
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-12-05+75,000775,000 total
    Exercise: $6.80Exp: 2034-01-17Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]Represents an option initially granted to the Reporting Person on January 17, 2024, a portion of which shares underlying this option shall vest upon the achievement of certain performance milestones. On December 5, 2024, the board of directors of the Issuer determined that one of the performance milestone conditions was achieved, resulting in the vesting of 75,000 shares.

Issuer

Prime Medicine, Inc.

CIK 0001894562

Entity typeother

Related Parties

1
  • filerCIK 0001714023

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 6:22 PM ET
Size
5.5 KB